Breakthrough trial aims to protect pregnant women and babies from malaria
NCT ID NCT06962319
Summary
This large study aims to find safe and effective malaria treatments for women in their first trimester of pregnancy. It will compare the current standard drug with newer options that may work better and be easier to take. Researchers will closely monitor the health of both mothers and their babies to ensure the treatments are safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA, PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Unit of Nanoro (CRUN), Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO)
NOT_YET_RECRUITINGNanoro, Burkina Faso
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
KEMRI Centre for Global Health Research (CGHR)
NOT_YET_RECRUITINGKisumu, 40100, Kenya
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako (USTTB),
RECRUITINGBamako, 1805, Mali
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.